logo
Editorial
Is epilepsy a curable neurodegenerative disease?
Serotonergic loss underlying apathy in Parkinson’s disease
Distinct pathways for cognitive decline in the presence of Alzheimer’s disease pathology or cerebrovascular disease
Amyloid imaging and Alzheimer’s disease
Catecholamines and cognition after traumatic brain injury
18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
Mislocated FUS is sufficient for gain-of-toxic-function amyotrophic lateral sclerosis phenotypes in mice
Defining secondary progressive multiple sclerosis
Neuroendothelial NMDA receptors as therapeutic targets in experimental autoimmune encephalomyelitis
Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline
The superficial white matter in temporal lobe epilepsy
Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline
Predicting hand function after hemidisconnection
Movement preparation and execution
The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson’s disease
Brain networks modulated by subthalamic nucleus deep brain stimulation
Relative impact of amyloid-β, lacunes, and downstream imaging markers on cognitive trajectories
Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer’s disease
Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study
Anticipation-related brain connectivity in bipolar and unipolar depression
A man of many quests
Role of cortico-pallidal connectivity in the pathophysiology of dystonia
Reply
Perifascicular necrosis in anti-synthetase syndrome beyond anti-Jo-1
Reply
Aberrant splicing induced by the most common EPG5 mutation in an individual with Vici syndrome
Reply